1-Jahres-Chart (nicht börsennotiert)
- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| CORNERSTONE THERAPEUTICS Aktie jetzt für 0€ handeln |
0 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| GILEAD SCIENCES | 86,67 | +0,10 % | Gilead's Livdelzi Shows Sustained Efficacy, Long-Term Safety In PBC Management | FOSTER CITY (dpa-AFX) - Gilead Sciences Inc. (GILD) announced data from a two-and-a-half-year interim analysis from the ongoing Phase 3 ASSURE study, which showed that 81% of participants with... ► Artikel lesen | |
| ZOETIS | 170,74 | +0,47 % | The Arthritis Foundation Welcomes Zoetis as Two-Year National Presenting Sponsor of Jingle Bell Run and Walk to Cure Arthritis | The partnership joins forces to support arthritis patients and their beloved pets ATLANTA, GA / ACCESSWIRE / November 12, 2024 / The Arthritis Foundation welcomes Zoetis, maker of innovative therapies... ► Artikel lesen | |
| INCYTE | 66,98 | -2,70 % | Aktie von Incyte an der Börse auf der Verliererseite: Börsenkurs fällt deutlich (62,00 €) | Keinen Grund zur Freude haben Anleger, die in den Anteilsschein von Incyte investiert haben: Der Kurs des Wertpapiers sackt kräftig ab. Zu den auffälligsten Werten im US-amerikanischen Wertpapierhandel... ► Artikel lesen | |
| AMARIN | 0,540 | +2,86 % | AMARIN CORP PLC - 8-K, Current Report | ||
| CASSAVA SCIENCES | 25,420 | -0,08 % | Cassava Sciences, Inc.: Cassava Sciences Appoints Freda Nassif as Chief Commercial Officer | ||
| LIGAND PHARMACEUTICALS | 115,00 | 0,00 % | ROUNDUP: Ligand Pharmaceuticals Boosts FY24 Outlook | WASHINGTON (dpa-AFX) - While reporting financial results for the third quarter on Thursday, biopharmaceutical company Ligand Pharmaceuticals, Inc. (LGND) raised its core adjusted earnings and... ► Artikel lesen | |
| ACHIEVE LIFE SCIENCES | 4,140 | +0,61 % | Achieve Life Sciences Promotes Jaime Xinos to Chief Commercial Officer to Advance Commercial Readiness of Cytisinicline | SEATTLE and VANCOUVER, British Columbia, Oct. 16, 2024 (GLOBE NEWSWIRE) -- Achieve Life Sciences, Inc. (Nasdaq: ACHV), a late-stage pharmaceutical company dedicated to the global development and commercialization... ► Artikel lesen | |
| MADRIGAL PHARMACEUTICALS | 332,50 | -0,33 % | Why Is Madrigal Pharmaceuticals, Inc. (MDGL) Among the Worst Performing Biotech Stocks in 2024? | ||
| SEELOS THERAPEUTICS | 2,000 | 0,00 % | After ALS trial misses mark, Seelos has filed for bankruptcy | ||
| ENZON PHARMACEUTICALS | 0,058 | -3,33 % | ENZON PHARMACEUTICALS, INC. - 10-Q, Quarterly Report | ||
| TALPHERA | 0,654 | -0,15 % | Talphera, Inc.: Talphera Announces Third Quarter 2024 Financial Results and Provides Corporate Update | Five sites actively screening with multiple patients having completed the study; two additional institutions expected to begin screening in the fourth quarter totaling... ► Artikel lesen | |
| ANI PHARMACEUTICALS | 53,00 | +2,91 % | ANI PHARMACEUTICALS INC - 8-K, Current Report | ||
| RIGEL PHARMACEUTICALS | 25,200 | +0,80 % | Rigel Pharmaceuticals Inc. Q3 Earnings Summary | WASHINGTON (dpa-AFX) - Below are the earnings highlights for Rigel Pharmaceuticals Inc. (RIGL):Earnings: $12.42 million in Q3 vs. -$5.69 million in the same period last year.
EPS: $0.70 in... ► Artikel lesen | |
| SAVARA | 3,120 | -3,11 % | Savara-Direktor Joseph McCracken erwirbt Stammaktien im Wert von 59.071 US-Dollar | ||
| MOLECULAR TEMPLATES | 0,338 | -7,70 % | Molecular Templates, Inc. Reports Second Quarter 2024 Financial Results and Corporate Update | Monotherapy activity of long duration in patients who have progressed on checkpoint therapy via a novel immuno-oncology mechanism of action with PD-L1 ETB (MT-6402) programEarly indication of monotherapy... ► Artikel lesen |
CORNERSTONE THERAPEUTICS INC gehört der Branche Pharma an.
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu CORNERSTONE THERAPEUTICS INC finden Sie auf Wallstreet Online.
